Musgrave PhD scholar in @Surgery_TCD funded by @BreakthroCancer |🔬 microRNA as a therapeutic target in pancreatic cancer | BSc. Pharmacology graduate UCD
I am delighted to share that our review on pancreatic cystic lesions and cancer risk stratification is now published!🎉 Grateful to my supervisors @JoanneLysaght and @sgmaher for their support and excited to celebrate my first first-author PhD publication! doi.org/10.1016/j.tranon.202…
Last week in Boston 🇺🇸, I was delighted to present my work on how microRNA-31-driven alterations in ATOX1 promote chemosensitivity in #PDAC at the @AACR/@theNCI/@EORTC International Conference on Molecular Targets and Cancer Therapeutics.
#PancreaticCancer#Targets25
Extremely grateful to have received a travel grant from @News_IACR to attend this meeting. Huge thanks to @BreakthroCancer & @Musgraveplc for funding this research, and to my supervisors @sgmaher & @prinamea for their continued guidance and support.
Prof @aislingbarryro Chair of Radiation Oncology at UCC joined @RochfordNiall today as he began his 250km #Cork2Cong walk in memory of his wife Stella đź’ś.
Niall started his 12-day journey from @UCC where Stella once studied, to raise awareness and funds for pancreatic cancer.
Delighted to present my work at @AACR-@theNCI-@EORTC Intl Conference on Molecular Targets and Cancer Therapeutics in Boston. If you’re at the conference, please stop by my poster tomorrow (C100) to chat about miR-31/ATOX1 targeting in #PDAC#Targets25aacrjournals.org/mct/article…
Had a great time volunteering at the @BreakthroCancer Revolution Exhibition in Stephen’s Green Shopping Centre today! Loved @DeasyPamela’s inspiring story—every journey is unique, and this exhibition captures it. Definitely worth a visit!
Free tickets at cancerrevolution.ie
💙 At the heart of research, it’s people who make the biggest impact.
PhD researcher @_davidhackett and @DeasyPamela survivor of #PancreaticCancer show how Public and Patient Involvement #PPI builds trust, focus and hope for the future.
Read more 👉 bit.ly/BCRPPI
PhD student, @Lorrainesmith_1 is exploring a new way to treat Barrett’s oesophagus using electroporation - a gentler method.
Funded by @BreakthroCancer through the @AllCaN_BCR programme, her work could pave the way for a new clinical trial for people with #BarrettsOesophagus
Congratulations to the formidable Dr Marion on a successful PhD viva! Delighted to see your hard work recognised. Such an impressive body of work revealing the pro-tumourigenic effects of fractalkine in OAC @caroline_mrn@JoanneLysaght@TCDTMI@CancerInstIRE@TrinityMed1
Early diagnosis of #OvarianCancer could raise survival to 90% - but it’s hard to detect.
At @TCDTMI, Dr. Sharon O’Toole & Marika Kanjuga are developing a blood test to catch it earlier.
Funded by Breakthrough Cancer Research & the Attracta O’Regan Fund 💙
#WOCD2025 @OvCancerDay
Exciting to see amifostine repurposed as a radioprotective agent for pancreatic cancer! Traditionally administered intravenously, a targeted nasal delivery method delivers it directly to the duodenum, where it shields healthy cells from radiation. Now entering clinical trials.
Congratulations to @nicraftery who presented at the European Surgical Association yesterday in Geneva on grading of dysplasia in Barrett’s and long-term progression. Thanks to all involved in this significant body of work. @OesophagealCF@ICATProgramme@CancerInstIRE@TrinityMed1